SBL
AVNS

Sargent Bickham Lagudis’s Avanos Medical AVNS Stock Holding History

Sargent Bickham Lagudis’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-62
Closed -$3K – 788
2017
Q3 		$3K Hold
62
– – ﹤0.01% 725
2017
Q2 		$2K Hold
62
– – ﹤0.01% 714
2017
Q1 		$2K Hold
62
– – ﹤0.01% 697
2016
Q4 		$2K Buy
+62
New +$2.22K ﹤0.01% 667
2016
Q2 		– Sell
-34
Closed -$1K – 712
2016
Q1 		$1K Buy
+34
New +$906 ﹤0.01% 695

Other funds holding AVNS

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PIM
Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Sargent Bickham Lagudis's AVNS Position: Q4 2017 in Review

Sargent Bickham Lagudis sold out of Avanos Medical (AVNS) in Q4 2017, closing a stake of 62 shares — an estimated $3K sold.

Sargent Bickham Lagudis first reported a position in AVNS in Q1 2016 and held it in 5 quarters. The position peaked at $3K in Q3 2017. 350 funds tracked by Wall St. Rank hold AVNS as of Q4 2017.

  • Sargent Bickham Lagudis reported no remaining Avanos Medical position as of Q4 2017 after selling out during the quarter.
  • Sargent Bickham Lagudis sold 62 Avanos Medical shares in Q4 2017, an estimated $3K.
  • Sargent Bickham Lagudis first reported a position in Avanos Medical in Q1 2016 and held it in 5 quarters.
  • Sargent Bickham Lagudis's Avanos Medical position peaked at $3K in Q3 2017.
  • 350 funds tracked by Wall St. Rank held Avanos Medical as of Q4 2017.

Based on Sargent Bickham Lagudis's 13F filing for Q4 2017, filed 13 Sep 2021.